JP2003516151A5 - - Google Patents

Download PDF

Info

Publication number
JP2003516151A5
JP2003516151A5 JP2001544332A JP2001544332A JP2003516151A5 JP 2003516151 A5 JP2003516151 A5 JP 2003516151A5 JP 2001544332 A JP2001544332 A JP 2001544332A JP 2001544332 A JP2001544332 A JP 2001544332A JP 2003516151 A5 JP2003516151 A5 JP 2003516151A5
Authority
JP
Japan
Prior art keywords
composition
compound
uncharged
bond
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001544332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003516151A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/042391 external-priority patent/WO2001042457A2/en
Publication of JP2003516151A publication Critical patent/JP2003516151A/ja
Publication of JP2003516151A5 publication Critical patent/JP2003516151A5/ja
Pending legal-status Critical Current

Links

JP2001544332A 1999-11-29 2000-11-29 細菌16Sおよび23SrRNAに標的化された、荷電していないアンチセンスオリゴヌクレオチド、ならびにその使用 Pending JP2003516151A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16815099P 1999-11-29 1999-11-29
US60/168,150 1999-11-29
PCT/US2000/042391 WO2001042457A2 (en) 1999-11-29 2000-11-29 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses

Publications (2)

Publication Number Publication Date
JP2003516151A JP2003516151A (ja) 2003-05-13
JP2003516151A5 true JP2003516151A5 (https=) 2008-01-17

Family

ID=22610334

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001544332A Pending JP2003516151A (ja) 1999-11-29 2000-11-29 細菌16Sおよび23SrRNAに標的化された、荷電していないアンチセンスオリゴヌクレオチド、ならびにその使用

Country Status (9)

Country Link
US (2) US6677153B2 (https=)
EP (1) EP1238071B1 (https=)
JP (1) JP2003516151A (https=)
KR (1) KR20020064915A (https=)
AT (1) ATE393221T1 (https=)
AU (1) AU783874B2 (https=)
CA (1) CA2392685C (https=)
DE (1) DE60038695T2 (https=)
WO (1) WO2001042457A2 (https=)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003516151A (ja) * 1999-11-29 2003-05-13 エイブイアイ バイオファーマ, インコーポレイテッド 細菌16Sおよび23SrRNAに標的化された、荷電していないアンチセンスオリゴヌクレオチド、ならびにその使用
US6784291B2 (en) 2000-05-04 2004-08-31 Avi Biopharma, Inc. Splice-region antisense composition and method
US6699670B2 (en) * 2001-03-01 2004-03-02 The Johns Hopkins University Quantitative assay for the simultaneous detection and speciation of bacterial infections
CA2463689C (en) * 2001-10-15 2011-04-26 Nissin Food Products Co., Ltd. Primers and method of detecting bacteria
GB0126415D0 (en) * 2001-11-02 2002-01-02 Univ Warwick Enzymes and enzyme inhibition
US20070021345A1 (en) * 2003-06-30 2007-01-25 Ehud Gazit Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
US7781396B2 (en) * 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US7491699B2 (en) * 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
ATE426575T1 (de) * 2003-01-07 2009-04-15 Univ Ramot Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
JP2004313181A (ja) 2003-04-02 2004-11-11 Canon Inc 感染症起炎菌検出用プローブ及びプローブセット、ならびに担体及び遺伝子検査方法
US7750142B2 (en) * 2003-04-28 2010-07-06 Isis Pharmaceuticals, Inc. Modulation of glucagon receptor expression
US7399853B2 (en) 2003-04-28 2008-07-15 Isis Pharmaceuticals Modulation of glucagon receptor expression
US7468418B2 (en) 2003-04-29 2008-12-23 Avi Biopharma., Inc. Compositions for enhancing transport of molecules into cells
US20080311556A1 (en) * 2003-08-07 2008-12-18 Iversen Patrick L Sense Antiviral Compound and Method for Treating Ssrna Viral Infection
US20050222068A1 (en) * 2003-10-23 2005-10-06 Mourich Dan V Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
EP1663199B1 (en) * 2003-09-25 2013-04-03 Tel Aviv University Future Technology Development L.P. Compositions and methods using same for treating amyloid-associated diseases
WO2005031362A2 (en) * 2003-10-02 2005-04-07 Ramot At Tel Aviv University Ltd. Novel antibacterial agents and methods of identifying and utilizing same
US20050171044A1 (en) * 2003-12-24 2005-08-04 Stein David A. Oligonucleotide compound and method for treating nidovirus infections
US8007847B2 (en) * 2004-01-13 2011-08-30 Eytan Biderman Feeding formula appliance
CA2553104A1 (en) 2004-01-23 2005-08-11 Avi Biopharma, Inc. Antisense oligomers and methods for inducing immune tolerance and immunosuppression
US7402574B2 (en) * 2004-03-12 2008-07-22 Avi Biopharma, Inc. Antisense composition and method for treating cancer
EP2351839A3 (en) * 2004-07-02 2011-10-05 AVI BioPharma, Inc. Antisense antibacterial method and compound
US20090156471A1 (en) * 2004-07-15 2009-06-18 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
EP1781310B1 (en) * 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Articles of peptide nanostructures and method of forming the same
US7732479B2 (en) 2004-08-19 2010-06-08 Tel Aviv University Future Technology Development L.P. Compositions for treating amyloid associated diseases
WO2006027780A2 (en) * 2004-09-08 2006-03-16 Ramot At Tel Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
US8129352B2 (en) * 2004-09-16 2012-03-06 Avi Biopharma, Inc. Antisense antiviral compound and method for treating ssRNA viral infection
US8357664B2 (en) * 2004-10-26 2013-01-22 Avi Biopharma, Inc. Antisense antiviral compound and method for treating influenza viral infection
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
EP1855694B1 (en) 2005-02-09 2020-12-02 Sarepta Therapeutics, Inc. Antisense composition for treating muscle atrophy
US20060240032A1 (en) * 2005-03-31 2006-10-26 Hinrichs David J Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases
US7300631B2 (en) * 2005-05-02 2007-11-27 Bioscale, Inc. Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
US20060293268A1 (en) * 2005-05-05 2006-12-28 Rieder Aida E Antisense antiviral compounds and methods for treating foot and mouth disease
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
US20060292575A1 (en) * 2005-06-24 2006-12-28 Asiagen Corporation Novel method for diagnosing pathogens of sexually transmitted diseases
US8067571B2 (en) * 2005-07-13 2011-11-29 Avi Biopharma, Inc. Antibacterial antisense oligonucleotide and method
US7790694B2 (en) * 2005-07-13 2010-09-07 Avi Biopharma Inc. Antisense antibacterial method and compound
WO2007030576A2 (en) * 2005-09-08 2007-03-15 Avi Biopharma, Inc. Antisense antiviral compound and method for treating picornavirus infection
US8524676B2 (en) * 2005-09-08 2013-09-03 Sarepta Therapeutics, Inc. Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds
JP4827483B2 (ja) * 2005-10-04 2011-11-30 キヤノン株式会社 核酸試料処理装置
EP1973928A2 (en) * 2005-10-11 2008-10-01 Ramot at Tel-Aviv University Ltd. Self-assembled fmoc-ff hydrogels
US7879212B2 (en) * 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes
US8501704B2 (en) 2005-11-08 2013-08-06 Sarepta Therapeutics, Inc. Immunosuppression compound and treatment method
US7582615B2 (en) * 2006-03-07 2009-09-01 Avi Biopharma, Inc. Antisense antiviral compound and method for treating arenavirus infection
WO2007123386A1 (es) * 2006-04-24 2007-11-01 Sigma Alimentos, S.A. De C.V. Método para la detección y cuantificación múltiple y simultánea de patógenos mediante la reacción en cadena de la polimerasa en tiempo real
PL2735568T3 (pl) * 2006-05-10 2018-02-28 Sarepta Therapeutics, Inc. Analogi oligonukleotydowe mające kationowe połączenia pomiędzy podjednostkami
US8785407B2 (en) * 2006-05-10 2014-07-22 Sarepta Therapeutics, Inc. Antisense antiviral agent and method for treating ssRNA viral infection
US20070265215A1 (en) * 2006-05-11 2007-11-15 Iversen Patrick L Antisense restenosis composition and method
US7598040B2 (en) 2006-11-22 2009-10-06 Trana Discovery, Inc. Compositions and methods for the identification of inhibitors of protein synthesis
US20090035767A1 (en) * 2006-11-28 2009-02-05 Canon Kabushiki Kaisha Primer for bacterium genome amplification reaction
US20080173652A1 (en) * 2007-01-23 2008-07-24 Bob Chou Integral heat-resisting structure of a disposable drinking cup
EP2121987B1 (en) 2007-02-09 2012-06-13 Northwestern University Particles for detecting intracellular targets
EP2160464B1 (en) 2007-05-30 2014-05-21 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
EP1997907A1 (en) 2007-06-01 2008-12-03 Friesland Brands B.V. Bifidobacteria
EP2201118B1 (en) * 2007-09-14 2012-04-18 Trana Discovery Compositions and methods for the identification of inhibitors of retroviral infection
CN102112625B (zh) * 2008-03-03 2013-11-20 学校法人埼玉医科大学 造成急性呼吸道感染的炎性病原体的鉴别方法
KR100966015B1 (ko) * 2008-03-24 2010-06-24 이화여자대학교 산학협력단 식중독 병원균의 동시 검출용 프라이머 및 이의 용도
EP2342339A4 (en) * 2008-09-29 2012-06-06 Trana Discovery Inc SCREENING PROCEDURE FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS
EP2365803B1 (en) 2008-11-24 2017-11-01 Northwestern University Polyvalent rna-nanoparticle compositions
EP2376633A1 (en) * 2008-12-17 2011-10-19 AVI BioPharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
AU2010203474B2 (en) * 2009-01-08 2015-11-19 Northwestern University Inhibition of bacterial protein production by polyvalent oligonucleotide modified nanoparticle conjugates
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
CN102449170A (zh) 2009-04-15 2012-05-09 西北大学 寡核苷酸功能化的纳米颗粒的递送
CA3128851C (en) 2009-06-23 2025-05-27 Gen-Probe Incorporated COMPOSITIONS AND METHODS FOR DETECTING A NUCLEIC ACID FROM MOLLICUTES
WO2011019993A2 (en) * 2009-08-14 2011-02-17 Epicentre Technologies Corporation METHODS, COMPOSITIONS, AND KITS FOR GENERATING rRNA-DEPLETED SAMPLES OR ISOLATING rRNA FROM SAMPLES
CA2779099C (en) 2009-10-30 2021-08-10 Northwestern University Templated nanoconjugates
EP2499248B1 (en) 2009-11-13 2017-01-04 Sarepta Therapeutics, Inc. Antisense antiviral compound and method for treating influenza viral infection
AU2011207563B2 (en) 2010-01-19 2016-03-10 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
US20130101512A1 (en) 2010-03-12 2013-04-25 Chad A. Mirkin Crosslinked polynucleotide structure
KR20200133284A (ko) 2010-05-28 2020-11-26 사렙타 쎄러퓨틱스, 인코퍼레이티드 변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체
US8198429B2 (en) 2010-08-09 2012-06-12 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
US10017763B2 (en) 2010-09-03 2018-07-10 Sarepta Therapeutics, Inc. dsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
AU2011326364B2 (en) * 2010-11-12 2016-08-11 Sarepta Therapeutics, Inc. Antisense antibacterial compounds and methods
TW201225972A (en) 2010-11-15 2012-07-01 Univ Ramot Dipeptide analogs for treating conditions associated with amyloid fibril formation
AU2012308302A1 (en) 2011-09-14 2014-03-20 Northwestern University Nanoconjugates able to cross the blood-brain barrier
WO2013043817A1 (en) 2011-09-20 2013-03-28 Isis Phamaceuticals, Inc. Antisense modulation of gcgr expression
US20140259222A1 (en) * 2011-09-21 2014-09-11 Syngenta Participation Ag Pathogen resistance
US20130085139A1 (en) 2011-10-04 2013-04-04 Royal Holloway And Bedford New College Oligomers
HK1201514A1 (en) 2011-11-18 2015-09-04 Sarepta Therapeutics, Inc. Functionally-modified oligonucleotides and subunits thereof
US9556439B2 (en) 2012-02-09 2017-01-31 Bavarian Nordic A/S Agonists and antagonists of toll-like receptor (TLR) 13
JP5800443B2 (ja) * 2012-11-09 2015-10-28 株式会社村田製作所 二次電池、及び二次電池の充放電方法
EP3024936B1 (en) 2013-07-25 2019-09-04 Exicure, Inc. Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
US10182988B2 (en) 2013-12-03 2019-01-22 Northwestern University Liposomal particles, methods of making same and uses thereof
WO2015170979A1 (en) * 2014-05-06 2015-11-12 Is-Diagnostics Ltd. Microbial population analysis
TR201908550T4 (tr) 2014-06-04 2019-07-22 Exicure Inc Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi.
WO2016028940A1 (en) 2014-08-19 2016-02-25 Northwestern University Protein/oligonucleotide core-shell nanoparticle therapeutics
CR20170181A (es) 2014-10-06 2017-05-31 Exicure Inc Compuestos anti-tnf
CN108474042B (zh) * 2014-10-17 2022-02-11 弗雷德哈钦森癌症研究中心 一种评估幽门螺杆菌感染的试剂成分,试剂盒以及方法
US11213593B2 (en) 2014-11-21 2022-01-04 Northwestern University Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
MA41795A (fr) 2015-03-18 2018-01-23 Sarepta Therapeutics Inc Exclusion d'un exon induite par des composés antisens dans la myostatine
US11020417B2 (en) 2015-06-04 2021-06-01 Sarepta Therapeutics, Inc Methods and compounds for treatment of lymphocyte-related diseases and conditions
US11142764B2 (en) 2015-12-23 2021-10-12 Board Of Regents, The University Of Texas System Antisense antibacterial compounds and methods
WO2017196941A1 (en) * 2016-05-10 2017-11-16 American Molecular Laboratories, Inc. Methods and compositions for characterizing drug resistant bacteria from formalin-fixed paraffin-embedded biological samples
MX2020000387A (es) 2017-07-13 2020-08-17 Univ Northwestern Método general y directo para preparar nanopartículas de estructura organometálica funcionalizadas con oligonucleotidos.
AU2018313765A1 (en) * 2017-08-07 2020-02-27 Finch Therapeutics, Inc. Compositions and methods for decolonizing antibotic-resistant bacteria in the gut
EP3728601A4 (en) * 2018-01-17 2021-03-17 Augmanity Nano Ltd ANTI-PATHOGENIC NUCLEIC ACID SET, THEIR COMPOSITIONS AND USES
EP3952645A4 (en) * 2019-04-08 2023-08-23 University Of Massachusetts Localization of payload delivery systems to tumor sites via beacon cell targeting
US12319711B2 (en) 2019-09-20 2025-06-03 Northwestern University Spherical nucleic acids with tailored and active protein coronae
US12378560B2 (en) 2019-10-29 2025-08-05 Northwestern University Sequence multiplicity within spherical nucleic acids

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5220014A (en) * 1989-11-13 1993-06-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Rrna specific oligonucleotides
AU655164B2 (en) * 1989-12-20 1994-12-08 Antivirals Inc. Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
US5852188A (en) 1990-01-11 1998-12-22 Isis Pharmaceuticals, Inc. Oligonucleotides having chiral phosphorus linkages
US5821052A (en) 1992-04-16 1998-10-13 University Of Medicine And Dentistry Of New Jersey Control of the synthesis of proteins by anitisense RNA-tRNA complex
US6060456A (en) 1993-11-16 2000-05-09 Genta Incorporated Chimeric oligonucleoside compounds
GB9505438D0 (en) 1995-03-17 1995-05-03 Sod Conseils Rech Applic Antisense oligonucleotides
AU3811897A (en) 1996-07-24 1998-02-10 Oglios Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
CA2278924A1 (en) * 1997-01-24 1998-07-30 Avi Biopharma, Inc. Method and conjugate for treating h. pylori infection
CN1263473A (zh) 1997-05-21 2000-08-16 利兰·斯坦福青年大学托管委员会 增加跨生物膜转运的组合物和方法
US6204019B1 (en) 1997-06-04 2001-03-20 Smithkline Beecham Corporation Sec A2 from Streptococcus pneumoniae
US6610539B1 (en) 1997-07-10 2003-08-26 Genesense Technologies, Inc. Antisense oligonucleotide sequences as inhibitors of microorganisms
EP0894857A3 (en) 1997-08-01 2001-09-26 Smithkline Beecham Corporation SecA gene from Streptococcus pneumoniae
US6133246A (en) 1997-08-13 2000-10-17 Isis Pharmaceuticals Inc. Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
US6228579B1 (en) 1997-11-14 2001-05-08 San Diego State University Foundation Method for identifying microbial proliferation genes
JP2003516151A (ja) 1999-11-29 2003-05-13 エイブイアイ バイオファーマ, インコーポレイテッド 細菌16Sおよび23SrRNAに標的化された、荷電していないアンチセンスオリゴヌクレオチド、ならびにその使用
AU781676B2 (en) 2000-01-04 2005-06-02 Avi Biopharma, Inc. Antisense antibacterial cell division composition and method

Similar Documents

Publication Publication Date Title
JP2003516151A5 (https=)
CA2392685A1 (en) Antisense antibacterial method and composition
JP5801205B2 (ja) 多価オリゴヌクレオチド修飾ナノ粒子コンジュゲートによる細菌タンパク質産生の阻害
US7049431B2 (en) Antisense antibacterial cell division composition and method
CN115697420A (zh) 一种治疗赫勒氏综合征的方法和药物
US8067571B2 (en) Antibacterial antisense oligonucleotide and method
JP2023548584A5 (https=)
US7790694B2 (en) Antisense antibacterial method and compound
JP2003518946A5 (https=)
JP2004509619A5 (https=)
AU2006267051B2 (en) Antisense antibacterial method and compound
JP2019531763A5 (https=)
JP7770769B2 (ja) 免疫刺激性オリゴヌクレオチド
CA2358570C (en) Protonated/acidified nucleic acids and methods of use
JP2024112834A5 (https=)
JP2024516183A5 (https=)
JP2005504522A5 (https=)
JP2019500902A5 (https=)
Versalovic et al. Interspersed repetitive sequences in bacterial genomes
US6136602A (en) Oligonucleotides specific for the marORAB operon
JP2007501621A5 (https=)
RU2024106447A (ru) Антисмысловые олигонуклеотиды, нацеленные на ген cav3.1, и их применения
KR100814718B1 (ko) 항 박테리아 활성을 갖는 pna 변이체 화합물, 그를포함하는 박테리아 감염 예방 또는 치료용 조성물,비생물체를 소독하기 위한 조성물 및 비생물체를 소독하는방법
WO2001027262A1 (en) Gene selection using pnas
Tauch et al. A Corynebacterium Plasmid Composed of Elements from Throughout the Eubacteria